BACE1 and Alzheimer disease: Interestingly, both the expression and activity of BACE-1 appear to be elevated in the cerebrospinal fluid and brains of AD patients [9,10] suggesting that BACE-1 expression is altered in AD and that therapeutic approaches aimed at regulating BACE-1 expression may be successful.